Pacira Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Pacira Pharmaceuticals Inc
TickerPCRX
CIK #0001396814
CUSIP695127100
SectorLife Sciences - Pharmaceutical Preparations
Address5 Sylvan Way Suite 125, Parsippany, NJ 07054
Source [EDGAR]
CIK Filing 2011 - 2025
[0001396814] 10-K
[0001396814] 10-Q
[0001396814] 3
[0001396814] 4
[0001396814] 5
[0001396814] 8-K
[0001396814] SC 13D
[0001396814] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Renaissance Technologies LLC Pacira Biosciences Inc [2025-08-13] 0.0
DOMA Perpetual Capital Management LLC Pacira Biosciences Inc [2025-08-08] 0.0
Pacer Advisors Inc Pacira Biosciences Inc [2025-05-02] 0.0
Millennium Management LLC Pacira Biosciences Inc [2025-01-15] 0.0
Baillie Gifford & Co Pacira Biosciences Inc [2022-01-27] 5.29
Renaissance Technologies LLC Pacira Biosciences Inc [2021-02-10] 6.04
Integrated Core Strategies US LLC Pacira Biosciences Inc [2019-09-30] 1.4
Macquarie Group Ltd Pacira Pharmaceuticals Inc [2019-02-14] 5.2
Consonance Capital Management LP Pacira Pharmaceuticals Inc [2018-10-22] 8.9
Partner Fund Management LP Pacira Pharmaceuticals Inc [2018-04-16] 5.9
Point72 Asset Management LP Pacira Pharmaceuticals Inc [2017-08-22] 5.0
HealthCor Management LP Pacira Pharmaceuticals Inc [2017-08-14] 6.2
Partner Fund Management LP Pacira Pharmaceuticals Inc [2017-04-17] 5.7
Visium Asset Management LP Pacira Pharmaceuticals Inc [2015-08-10] 5.1
Vanguard Group Inc Pacira Pharmaceuticals Inc [2014-02-12] 5.36
Gilder Gagnon Howe & Co LLC Pacira Pharmaceuticals Inc [2014-02-12] 11.49
BlackRock Inc Pacira Pharmaceuticals Inc [2014-01-30] 6.5
FMR LLC Pacira Pharmaceuticals Inc [2013-09-10] 0.0
Prudential Financial Inc Pacira Pharmaceuticals Inc [2013-02-13] 6.7
Jennison Associates LLC Pacira Pharmaceuticals Inc [2013-02-11] 6.7
Gilder Gagnon Howe & Co LLC Pacira Pharmaceuticals Inc [2012-11-13] 11.02
Visium Asset Management LP Pacira Pharmaceuticals Inc [2012-04-20] 6.03
Form 3/4/5 Filer 2011 - 2025
Bigal Marcelo
Pacira BioSciences, Inc.
Slonin Jonathan
Kronenfeld Mark A.
Ceesay Abraham
Froimson Mark
Yang Michael J
Young Alethia
Christie Christopher
Brege Laura
Riker Lauren
Williams Kristen
Teehan Brendan
Lee Frank D.
Gaugler Daryl
Cross Shawn
Reinhart Charles A. III
Hastings Paul J
Pace Gary W
Winston Roy
Stack David M
McLoughlin Dennis
Ellis Ronald J. Jr.
Reinhardt Max
Molloy Anthony
Laranjeira Charles Anthony
Greenstreet Yvonne
Longenecker John P PhD
Manning Donald C.
Wicki Andreas
TELA Bio, Inc.
Scranton Richard
Weiland Robert J.
Braunstein Scott
Jones James B
Winger Dennis L
Scibetta James S
Markvicka Taunia
Patou Gary
Middleton Fred A
Pratt John
Evnin Luke
HBM Healthcare Investments (Cayman) Ltd.
Sanderling Venture Partners VI LP
Sanderling Ventures Management VI
Sanderling VI Limited Partnership
Sanderling VI Beteiligungs GmbH & Co KG
Sanderling Venture Partners VI Co Investment Fund LP
Scopa James Paul
Foley Todd
MPM BioVentures IV GmbH & Co. Beteiligungs KG
MPM BioVentures IV LLC
Vander Vort John
MPM Asset Management Investors BV4 LLC
MPM BioVentures IV GP LLC
MPM BioVentures IV QP LP
Kailian Vaughn M
Gadicke Ansbert
OrbiMed Capital GP III LLC
OrbiMed Advisors LLC
Isaly Samuel D
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 7,567,762 7,795,717
Vanguard Group Inc [2025-06-30] SOLE 0 5,266,132
Renaissance Technologies LLC [2025-06-30] SOLE 2,395,601 2,395,601
D. E. Shaw & Co., Inc. [2025-06-30] DFND 2,250,065 2,253,365
Balyasny Asset Management LP [2025-06-30] SOLE 2,130,733 2,130,733
Dimensional Fund Advisors LP [2025-06-30] SOLE 1,997,803 2,056,135
State Street Corp [2025-06-30] DFND 1,830,503 1,950,603
DOMA Perpetual Capital Management LLC [2025-06-30] SOLE 1,804,069 1,804,069
Goldman Sachs Group Inc [2025-06-30] DFND 1,307,747 1,308,901
American Century Companies Inc [2025-06-30] DFND 1,182,513 1,182,513
Geode Capital Management LLC [2025-06-30] DFND 1,143,190 1,143,190
UBS Group AG [2025-06-30] DFND 1,020,695 1,028,889
Jacobs Levy Equity Management Inc [2025-06-30] SOLE 694,409 984,742
Morgan Stanley [2025-06-30] DFND 796,330 950,036
Polar Capital Holdings Plc [2025-06-30] DFND 910,455 910,455
Millennium Management LLC [2025-06-30] SOLE 515,024 695,324
J Goldman & Co LP [2025-06-30] SOLE 656,564 656,564
Charles Schwab Investment Management Inc [2025-06-30] SOLE 570,047 570,079
Northern Trust Corp [2025-06-30] DFND 551,283 560,848
Wellington Management Group LLP [2025-06-30] DFND 0 545,602
Assenagon Asset Management S.A. [2025-06-30] SOLE 482,964 482,964
Invesco Ltd. [2025-06-30] DFND 0 479,399
Impax Asset Management Group plc [2025-06-30] DFND 470,027 470,027
Bridgeway Capital Management LLC [2025-06-30] SOLE 460,273 460,273
EcoR1 Capital LLC [2025-06-30] SOLE 457,471 457,471
Nuveen, LLC [2025-06-30] DFND 389,573 390,632
Pacer Advisors Inc [2025-06-30] SOLE 386,629 386,629
Bank of New York Mellon Corp [2025-06-30] DFND 357,229 386,334
Deutsche Bank AG [2025-06-30] DFND 300,097 373,804
Gagnon Securities LLC [2025-06-30] SOLE 0 368,353
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com